Nationwide Trends in Incidence, Healthcare Utilization, and Mortality in Hospitalized Acute Myocardial Infarction Patients in Taiwan - Trial NCT05974397
Access comprehensive clinical trial information for NCT05974397 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Pharmaceuticals and is currently Completed. The study focuses on Acute Myocardial Infarction. Target enrollment is 124018 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Novartis Pharmaceuticals
Novartis
Timeline & Enrollment
N/A
Sep 30, 2021
Jul 22, 2022
Primary Outcome
Mean age of patients,Number of male patients,Year of patient entry into cohort,Number of patients with AMI in Taiwan,Number of patients with STEMI in Taiwan,Number of patients with NSTEMI in Taiwan,Number of AMI patients with comorbidities,Number of patients with treatment for AMI,Number of STEMI patients with comorbidities,Number of patients with treatment for STEMI,Number of NSTEMI patients with comorbidities,Number of patients with treatment for NSTEMI,Number of mortalities among AMI patients,Number of mortalities among STEMI patients,Number of mortalities among NSTEMI patients,Number of AMI patients with outpatient visits,Number of AMI patients with emergency room visits,Number of AMI patients with hospitalizations,Length of hospital stay for AMI patients,Direct medical costs for AMI patients,Number of STEMI patients with outpatient visits,Number of STEMI patients with emergency room visits,Number of STEMI patients with hospitalizations,Length of hospital stay for STEMI patients,Direct medical costs for STEMI patients,Number of NSTEMI patients with outpatient visits,Number of NSTEMI patients with emergency room visits,Number of NSTEMI patients with hospitalizations,Length of hospital stay for NSTEMI patients,Direct medical costs for NSTEMI patients
Summary
This was a retrospective study using the Taiwan's National Health Insurance Research Database
 (NHIRD). The study employed two study designs for different purposes as follows:
 
 - A cross-sectional analysis was conducted to explore the annual incidence trends.
 
 - A longitudinal cohort study was conducted to assess baseline characteristics, treatment
 patterns, long-term healthcare utilization, and cause-specific mortality among incident
 AMI patients.
 
 In each part, the study was conducted for AMI, and separately for ST-segment elevation and
 non-ST- segment elevation myocardial infarction (STEMI and NSTEMI)
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05974397
Non-Device Trial